Study suggests limits on opioid dosage may not reduce overdoses

09/17/2013 | Medscape (free registration)

Restricting daily morphine dosages to 100 mg may not be an effective strategy to reduce overdoses, according to Purdue Pharma research released at PAINWeek 2013. The study, which cited age, sedative use and lack of a recent opioid prescription as factors in overdose risk, followed recommendations from Physicians for Rational Opioid Prescribing that included limiting doses for noncancer pain.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX